To print: Select File and then Print from your browser's menu
---------------------------------------------------------------------------------------
Title: Study Confirms Older Corneas Suitable for Transplantation
URL: http://www.pslgroup.com/dg/21F002.htm
Doctor's Guide
April 1, 2008

BETHESDA, Md -- April 1, 2008 -- The age pool of corneas for transplant should be expanded to include donors up to 75 years of age, based on findings from a study funded by the National Eye Institute (NEI), one of the National Institutes of Health (NIH). Corneal transplants using tissue from older donors have similar rates of survival to those using tissue from younger donors.

The 5-year transplant success rate was the same for transplants performed with corneas from donors ages 12 to 65 years (86%) and from donors ages 66 to 75 (86%), according to the study published in the April issue of Ophthalmology.

The availability of donor corneas has been adequate for the past 10 years in the United States, where more than 33,000 corneal transplants are performed each year. However, according to the study authors, recent changes in US Food and Drug Administration (FDA) regulations will likely cause a decrease in the supply of donated corneas. These new regulations that took effect in June 2007 require additional screening and testing of potential donors for contagious diseases, registration of eye banks, more detailed records and labels, and stricter quarantine procedures.

"With the expected decrease in the pool of eligible cornea donors in the United States and the existing shortage of corneal tissue internationally, it is encouraging that we now have scientific evidence showing that older corneas can be used reliably in corneal transplantations," said Elias A. Zerhouni, MD, Director, NIH, Bethesda, Md.

In addition, many eye banks previously set the age limit for donors at 65 years or younger because some surgeons have been reluctant to use older corneas. According to the study authors, their findings could lessen these restrictive policies. They estimate that use of older donor tissue could expand the donor pool by as much as 20% to 35%.

"This new research has come at a good time," said Paul A. Sieving, MD, PhD, Director, NEI, Bethesda, Md. "The pressure on eye banks to provide corneas is increasing. The results of this study will expand the available donor pool and should persuade surgeons to use corneas from older donors. These changes will greatly benefit the growing number of individuals who need corneal transplants."

"Surgeons and patients now have scientific evidence that older donor corneas are suitable for transplantation," said study co-chair Edward J. Holland, MD, Professor of Ophthalmology, University of Cincinnati, and Director, Cornea Service, Cincinnati Eye Institute, both in Cincinnati, Ohio. "Further, when corneas are readily available, transplant procedures can be scheduled more efficiently, allowing both surgeons and patients to plan for them."

The Cornea Donor Study (CDS), which was coordinated by the Jaeb Center for Health Research, Tampa, Florida., is a prospective cohort study conducted with 1,101 participants enrolled by 105 surgeons at 80 sites across the United States. Participants were between 40 and 80 years of age and were chosen for the study if they were in need of a corneal transplant for a corneal disease that put them at moderate risk for clouding of the transplanted cornea. Donor corneas were provided by 43 participating eye banks. All donor corneas met the Eye Bank Association of America's standards for human corneal transplantation and were consistent with eye banks' tissue ratings of good to excellent quality. After the transplant surgery, the participants were followed for 5 years. The transplant was considered a failure if a repeat corneal transplant was required or if the cornea was cloudy for at least 3 months.

In a secondary study, the researchers examined the fate of the corneas' endothelial cells. "Though there was cell loss in both age groups, in 86% of the cases the corneas remained clear after 5 years," said Jonathan H. Lass, MD, Professor and Chair, Department of Ophthalmology and Visual Sciences, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, Ohio, and medical director of the study's endothelial image reading centre. "These findings suggest the opportunity for further research to continue to perfect corneal transplants."

"The CDS is a landmark study," added study co-chair Mark J. Mannis, MD, Professor and Chair, Department of Ophthalmology, University of California, Davis, Davis, California. "It is the largest study of its type on corneal transplantation ever done. Its size and 5-year patient follow-up, along with a simple trial design, have provided us with clear and important insights into contemporary transplantation."


SOURCE: National Institutes of Health/National Eye Institute

---------------------------------------------------------------------------------------------
Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content.
---------------------------------------------------------------------------------------------
This news story was printed from *Doctor's Guide to the Internet*
located at http://www.docguide.com
---------------------------------------------------------------------------------------

Return to News Story Page

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.
All contents Copyright (c) 1998 P\S\L Consulting Group Inc.
All rights reserved.